<style face="normal" font="default" size="100%">Carfilozomib versus bortezomib for relapsed or refractory myeloma – Authors' reply</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Carfilozomib versus bortezomib for relapsed or refractory myeloma – Authors' reply</style>